openPR Logo
Press release

Memantine Market Report 2018-2026 Focuses On Top Companies Merz Pharmaceuticals, Lupin ,Allergan ,Novartis AG, Daiichi Sankyo Company, Ono Pharmaceutical

01-14-2019 03:04 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Memantine

Memantine

Memantine is a non-acetyl cholinesterase inhibitor drug that aids in treatment of Alzheimer's disease. The drug received European marketing approval in 2002 and the U.S. Food and Drug Administration (U.S FDA) approval in 2003. The generic versions of the drugs are available since 2015. Memantine aids in treatment of moderate to severe dementia associated with Alzheimer's disease. However the drug may show a severe skin reaction called Stevens-Johnson syndrome (associated with painful blisters on the skin) after prolonged use.

Memantine Market– Drivers

Increasing number of pipeline studies for use of memantine are expected to boost growth of the memantine market. For instance, in September 2016, Lille University Hospital started phase I clinical study for assessing the effects of memantine on cognitive behavior of patients associated with Alzheimer’s disease. The study is estimated to be completed by February 2019.

Furthermore, Suven Life Sciences Limited is undergoing phase II clinical study for the comparative study on safety and efficacy of SUVN-502 along with memantine HCl and donezepil HCl for treating moderate Alzheimer’s disease. The study was started in September 2015 and is expected to be completed in May 2019.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2255

Memantine Market– Taxonomy

By Formulation

Tablet
Capsule
By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Memantine Market– Restraint

Increasing number of expired patents of drugs is a major factor hindering growth of the global memantine market. For instance, according Merz Pharmaceuticals, a Germany-based company, in October 2018, overall licensing income during patented period for memantine decreased due to expiration of patent protection in a majority of markets. For instance, according to Merz Pharmaceuticals, the U.S. licensing income for memantine declined to US$ 138.07 million in 2017-18 compared to US$ 183.34 million in year 2016.

Memantine Market– Regional Analysis

On the basis of region, the global memantine market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the global memantine market, owing to increasing number of generic versions of memantine in the U.S. market. For instance, in February 2018, Lupin Limited announced the launch of its Memantine Hydrochloride Extended-Release Capsules in the U.S. market. The capsules are available in 7mg, 14mg, 21mg, and 28mg, for which company has received an approval from the U.S. FDA. These are indicated for the treatment of moderate to severe dementia of the Alzheimer’s disease.

Furthermore, Asia Pacific is expected to witness significant growth in the global memantine market, owing to increasing focus of key players in manufacturing memantine tablets. For instance, in October 2018, Dr. Reddy’s Laboratories launched memantine hydrochloride tablets in the Indian market. They are available in 5mg and 10mg, equivalent to generic version of Namenda tablets, which were already available in the U.S. market in July 2015.

Get Discount On This Report:
https://www.coherentmarketinsights.com/insight/request-discount/2255

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Memantine Market Report 2018-2026 Focuses On Top Companies Merz Pharmaceuticals, Lupin ,Allergan ,Novartis AG, Daiichi Sankyo Company, Ono Pharmaceutical here

News-ID: 1495742 • Views: 864

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Memantine

Memantine Market 2022 Professional Study with Industry Growth, Shares, Opportuni …
Coherent Market Insights has released a new research study on the "Memantine Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Memantine Market Report detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Memantine Market research report is an intelligence report that includes
Global Memantine Market: Top Investment Pockets in the Market| Allergan, Novarti …
LOS ANGELES, United States: QY Research as of late produced a research report titled, “Global Memantine Market Research Report 2020". The research report speak about the potential development openings that exist in the worldwide market. The report is broken down on the basis of research procedures procured from historical and forecast information. The global Memantine market is relied upon to develop generously and flourish as far as volume and incentive
Memantine Market 2020 - 2026 | In-depth Analysis by Top Players Merz Pharmaceuti …
The global Memantine Market research report thoroughly explains each and every aspect related to the Memantine Market, which facilitates the report's reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. The growth trend forecasted on account of thorough examination offers in-depth information regarding the global Memantine Market. A pathway of development is offered by the market to the several connected networks
Memantine Market Analysis 2018 –Allergan, Novartis AG, Eisai Co, H Lundbeck A/ …
UpMarketResearch published an exclusive report on “Memantine” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 96 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Memantine market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market
Alzheimer’s Drugs Market, by Drug (Donepezil, Rivastigmine, Galantamine and Me …
The Global Alzheimer’s Drugs Market, by Drug (Donepezil, Rivastigmine, Galantamine and Memantine) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 7 billion in 2016 and is projected to exhibit a CAGR of 9.5% over the forecast period (2017 – 2025), as highlighted in a new report published by Coherent Market Insights.
Alzheimer’s Drugs Market: Memantine drug type dominated the global market
The global Alzheimer's drugs market has a huge scope of growth in developing nations on account of limited awareness about this disease in various underdeveloped nations. According to a report by Transparency Market Research (TMR), players within the market which are based in Europe and North America are expected to lead in the coming years on account of the widespread presence of treatment channels for Alzheimer's across nations such